AR extract demonstrated significant antiproliferative and apoptotic effects, inducing caspase-3/7 and annexin V/PI activity, on MCF-7 breast cancer cells at concentrations of 20–200 μg/mL over 24–72 h, supporting its potential as a low-toxicity therapeutic candidate. Here, ANXA5 is linked to breast cancer.